Dehydroepiandrosterone modulates oxidative DNA damage in pancreatic cancer: A case-control study.

JGH Open · 2021 · PMC8341181 · PMID 34386598

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an expected trendno p-value reported

When we looked at the DHEA tertiles, an expected trend toward a reduced risk of pancreatic cancer was notable; therefore, the third tertile of DHEA compared to the first was associated with a lower risk of pancreatic cancer (adjusted OR = 0.05, 95% CI: 0.004–0.69).

also in 319 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.